Thu, Feb 26, 10:07 AM, Zacks
Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog
Is Pharmacyclics (PCYC) up for sale? J&J and Novartis are rumored to be interested in acquiring the company.
Mon, Feb 23, 5:20 PM, Zacks
Celgene Gains on Label Expansion of Revlimid in the EU - Analyst Blog
Celgene Corporation announced that Revlimid has received approval from the European Commission for the treatment of adults with previously untreated multiple myeloma who are not eligible for transplant.